Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nature Reviews. Cancer|October 19, 2007
Carboxypeptidase-G2-based gene-directed enzyme-prodrug therapy: a new weapon in the GDEPT armouryDouglas Hedley, Lesley Ogilvie, Caroline Springer
Omics : a Journal of Integrative Biology|October 18, 2023
One Health Lens for Antimicrobial Resistance Research and Funding: A Systematic ReviewIssam Alsamara, Lesley Ogilvie, Ralf Sudbrak, et al.
Trends in Microbiology|July 27, 2005
Metagenomic marine nitrogen fixation--feast or famine?Andrew W B Johnston, Youguo Li, Lesley Ogilvie
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 26, 2025
Investment gaps in antimicrobial resistance research & development: trends in Europe, 2017-2021Elisa Fabbro, Usha Lamichhane, Ralf Sudbrak, et al.
Cancer Research|April 3, 2004
V599EB-RAF is an oncogene in melanocytesClaudia Wellbrock, Lesley Ogilvie, Douglas Hedley, et al.
Cancer Research|October 5, 2006
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signalingNicolas Dumaz, Robert Hayward, Jan Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapyFrank Friedlos, Panos Lehouritis, Lesley Ogilvie, et al.
Vaccine|January 30, 2025
Vaccines and AMR: An analysis of the funding landscape for human bacterial vaccines in low-and middle-income countriesCatherine Fleck-Vidal, Anna Doubell, Christiane Gerke, et al.
Pigment Cell & Melanoma Research|December 17, 2009
Inducible expression of (V600E) Braf using tyrosinase-driven Cre recombinase results in embryonic lethalityNathalie Dhomen, Silvy Da Rocha Dias, Robert Hayward, et al.
Oncogene|June 23, 2004
B-RAF is a therapeutic target in melanomaMaria Karasarides, Antonio Chiloeches, Robert Hayward, et al.
Pageof 2